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Safe Limits of Contrast Vary with Hydration Volume:Prevention of Contrast-
Induced Nephropathy after Coronary Angiography
Ji-yan Chen1, Yong Liu1
1Department of cardiology, Guangdong Cardiovascular Institute, Guangdong general
hospital, Guangzhou, Guangdong
Background: There have been few studies of the prevention of contrast-induced
nephropathy(CIN)on investigating the effect of intravenous hydration volume on
relative safe maximum volume of contrast.This study investigated the effect of
intravenous hydration volume on the safe maximum volume of contrast.
Methods: The ratios of contrast volume to creatinine clearance(V/CrCl)and hydration
volume to body weight(HV/W)were determined in patients undergoing coronary
angiography. Receiver-operator characteristic(ROC)curve analysis based on the
maximum Youden index was used to identify the optimal cutoff for V/CrCl in all
patients and in different hydration volume sub-groups(HV/W12and>12).
Results: Eighty-six of 3273(2.63%)patients developed CIN.ROC curve analysis
indicated that V/CrCl>2.44 was a predictor for CIN in all patients
(sensitivity¼71.6%, speciﬁcity¼70.5%,C-statistic:0.780), and V/CrCl>2.44 was
signiﬁcantly and independently related to the risk of CIN (adjusted OR:4.157;95%
CI:2.449-7.059,p < 0.0001)(age > 75, diabetes, congestive heart failure, emergent
coronary angiography, anemia, hypertension, intra-aortic balloon pump, hypoten-
sion) and the risk of 2 year death (adjusted HR:2.62;95%CI:1.84-3.87, p<
0.0001), even after including other clinical and procedural variables in multivariate
logistic regression,the V/CrCl ratio for CIN was1.87 in the insufﬁcient
hydration subgroup (HV/W12,sensitivity¼67.9%,speciﬁcity¼64.4%,C-statisti-
c:0.739,adjusted OR:3.239;95%CI:1.312-7.995,p¼0.0108)and2.93in the sufﬁcient
subgroup(HV/W>12,sensitivity¼69.0%,speciﬁcity¼65.0%,C-statistic:0.732,adjusted
OR:3.040;95%CI:1.640-5.633,p¼0.0004).
Conclusions: Individual relative safe maximum volume of contrast during coronary
angiography adjusted with different hydration volume may be more reliable even with
the signiﬁcance of long-term prognosis. We could moderately relax limits of contrast
dose among patients with adequate hydration.
Table1. Univariate Analysis and Multivariate Associations between CIN and
V/CrCl for patients HV/W>12Variable
Univariate Analysis Multivariate Analysis
OR CI p OR CI p
V/CrCl>2.93 4.133 2.338-
7.307
<0.0001 3.040 1.640-
5.633
0.0004
Age 75
years
2.514 1.467-
4.306
0.001 1.964 1.084-
3.559
0.0259
Hypotension 3.745 2.187-
6.411
<0.0001 2.295 1.255-
4.196
0.0070
IABP 1.041 0.576-
1.880
0.894
Emergent
PCI
1.409 0.790-
2.512
0.246
Hypertension 2.845 1.623-
4.984
<0.0001 2.214 1.190-
4.122
0.0122
Diabetes 8.527 4.471-
16.264
<0.0001 4.139 1.985-
8.629
0.0002
CHF 5.294 1.910-
14.673
0.001
Anemia 1.872 1.092-
3.210
0.023TCT-259
Prevention of Radio-Contrast Mediated Acute Renal Injury with Intravenous
Sodium Bicarbonate - Results of the PRIMARY Trial
Fernando Boccalandro1, Laura Harmon2, Tallat Fahim3, Samia Sheikh4,
Juan C. Cardenas5, Janie Lopez6, Sudhir Amaram7, Manohar Angirekula1
1ProCare Odessa Heart Institute, Permian Research Foundation, TTUHSC/
Department of Internal Medicine, Odessa, TX, 2Scott and White, College Station, TX,
3Group Health Cooperative, Tacoma, WA, 4No Afﬁliation, Indiana, IN, 5TTUHSC/
Department of Internal Medicine, Odessa, TX, 6Procare Odessa Heart Institute,
Odessa, TX, 7ProCare Odessa Heart Institute, TTUHSC/Department of Internal
Medicine, Odessa, TX
Background: Radiocontrast-induced acute kidney injury (RAKI), is associated with
increased short and long-term mortality, and poor renal outcomes. The usefulness of
sodium bicarbonate (SB) compared with normal saline (NS) in preventing RAKI in
patients undergoing coronary angiography with renal dysfunction is controversial. The
goal of the PRIMARY study was to evaluate the 1-year and 5-year, clinical and renal
outcomes of SB versus NS in preventing RAKI, in patients with chronic kidneyB76 JACC Vol 64/11/Suppl B j September 13–17disease (CKD) stage III-IV undergoing coronary diagnostic and interventional
procedures.
Methods: Three-hundred and ninety six patients (n¼396) (mean age: 6712) (52%
males) with a GFR < 60 mL/min/1.73m2, undergoing elective coronary angiography
were included in the study using an iso-osmolar contrast agent. Patients were ran-
domized to receive either 154 mEq/L of intravenous ( I.V.) SB (n ¼ 192) or NaCl (n ¼
190) with 5% dextrose at 3 mL/kg for one hour before contrast administration fol-
lowed by 1 mL/kg/hr for 6 hours post- procedure. Renal function was measured in all
patients before, and 48 hours after contrast administration. Incidence of RAKI, in-
hospital, 1 year and 5 year mortality and renal outcomes were compared between
groups. RAKI was deﬁned as increase in serum creatinine > 0.5 mg/dL or an increase
from > 25% baseline within 48 hours after the administration of contrast.
Results: There were no statistically signiﬁcant differences in each group regarding
baseline demographics, medical therapy, renal function or co-morbidities, contrast
volume used, hydration volume pre- and post-procedure, coronary artery severity,
incidence of revascularization and ejection fraction.
No signiﬁcant differences between groups were noted in the incidence of RAKI [25
(13%) treated with SB vs. 31 (16%) with NS (p¼ 0.89)]. The in-hospital mortality, 1
or 5-year mortality or need for renal replacement therapy was not statistically different
between groups.
Conclusions: In patients with stage III-IV CKD undergoing diagnostic and/or inter-
ventional coronary angiographic procedures, the use of SB is as effective as NS in
preventing RAKI, with similar in-hospital, 1 and 5 year mortality and need for renal
replacement therapy.
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Long-Term Prospective Outcome Analysis in High-Risk Patients for Contrast-
Induced Acute Kidney Injury
Gabriele Pesarini1, Michele Pighi1, Sara Ariotti1, Angela Ferrara1,
Corrado Vassanelli1, Flavio L. Ribichini1
1University of Verona, Verona, Italy
Background: Contrast-induced acute kidney injury (CI-AKI) is associated to increased
morbidity, mortality, health costs and prolonged hospitalization. Common deﬁnitions
of CI-AKI are: a relative increase in Serum Creatinine (SCr) of at least 25% from the
baseline values (deﬁnition 1), an absolute increase in SCr concentration of at least 0.5
mg/dL (deﬁnition 2), and an absolute increase in SCr of at least 0.3 mg/dL (deﬁnition 3),
all presenting within 48-72 hours. This study has two main aims: a) to prospectively
describe the long-term outcomes in a population at high-risk of CI-AKI development b)
to clarify which deﬁnition of CK-AKI correlates best with long-term events.
Methods: Monocentric, prospective, observational registry enrolling patients under-
going coronary angiography with at least one of: age 75; diabetes; stages 2 or 3
chronic kidney disease (NKF) or ST-segment elevation myocardial infarction
(STEMI). Biochemical determinations were assessed at baseline under preventive
hydration and 12, 24, 48 and 72 hours thereafter. Blood examinations were repeated
also at 1 month and subsequently every 6 months after discharge.Primary clinical end-
point was a composite of death, MI and need for dialisys.
Results: We enrolled 216 patients (72% males; mean age 70 years) followed for a
median of 1121 days. Thirthy-nine patients(18.1%) developed CI-AKI by deﬁnition 1,
16(7.4%) by deﬁnition 2 and 37(17.1%) by deﬁnition 3. 20% of patients had baseline
mild/moderate renal dysfunction (GFR>30 mL/min/1.73m2), while 46.7% were di-
abetics. At complete FU we observed 10 CV deaths(4.6%), 5 non-CV deaths(2.3%),
9(4.2%) MIs, 7(3.2%) major stokes and 6(2.8%) need for chronic dialysis. At Cox-
regression only CI-AKI assessed by deﬁniton 3 predicted primary EP(p¼0.04; HR:
2.168; 95%CI: 1.193-4.734). Renal impairment persisted at 30 days in 40.5% of CI-
AKI deﬁnition 3 patients and was associated with worst long-term outcome(p<
0.001;HR4.758.95%CI:2.039-11.100).
Conclusions: High-risk CI-AKI patients had 13.9% primary EP at 3-years.An abso-
lute increase in SCr of at least 0.3 mg/dL seems within 72h seems the most clinically
useful CI-AKI deﬁnition. Persistent renal damage at 30 days correlates with poorer
outcomes.
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Comparison of Target Lesion Revascularization in Patients with Renal
Insufﬁciency after Sirolimus-eluting Stent and Everolimus-eluting Stent
Implantation: Three-year Outcomes from Single-center Retrospective Study
Suguru Otsuru1, Kazushige Kadota1, Shunsuke Kubo1, Yusuke Hyodo2,
Tahei Ichinohe2, Daiji Hasegawa1, Seiji Habara1, Takeshi Tada1, Hiroyuki Tanaka1,
Yasushi Fuku1, Tsuyoshi Goto1, Kazuaki Mitsudo1
1Kurashiki Central Hospital, Kurashiki, Japan, 2Kurashiki Central Hospital,
Kurashiki, Japan
Background: Everolimus-eluting stent (EES) is one of the most commonly used
newer generation drug-eluting stent (DES) in clinical practice. However, the relative
merits of EES against the previous gold-standard sirolimus-eluting stent (SES) for
patients with renal insufﬁciency (RI) have been less extensively assessed. We aimed to
evaluate the three-year outcomes after SES and EES implantation for patients with RI., 2014 j TCT Abstracts/Renal Insufﬁciency and Contrast Nephropathy
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMMethods: A total of 1926 patients underwent the ﬁrst SES implantation between
November 2002 and December 2006 and 651 patients underwent the ﬁrst EES im-
plantation between January 2010 and December 2010, whose target lesion revascu-
larization (TLR) were investigated by telephone follow-up, examining medical
records, and asking family physicians. The patients were stratiﬁed into 4 groups ac-
cording to their estimated glomerular ﬁltration rate (eGFR): Group I, eGFR 60 ml/
min/1.73m2 (normal renal function); Group II, eGFR ＜60 and 30 ml/min/1.73m2
(mild-moderate RI); Group III, eGFR ＜30 ml/min/1.73m2 and not on hemodialysis
(HD) (severe RI without HD); and Group IV, renal failure treated with HD (severe RI
with HD).
Results: The ﬁgure shows the cumulative incidence of TLR at 3 years in all cases and
group IV. Complete 3-year follow-up was achieved in 99.6% of SES (1919/1926) and
96.2% of EES (626/651). The cumulative incidence of TLR after EES implantation
tended to be lower than that after SES implantation in group I(log rank p< 0.001), II
(log rank p< 0.001) and III (log rank p:0.073).Conclusions: EES might reduce the cumulative incidence of TLR at long term follow
up, except for the patients with HD.
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Not Early Change in Serum Level Cystatin C, but Baseline Serum Cystatin C
Level Predicted Contrast Induced Nephropathy and Cardiovascular Mortality
Hyung-Bok Park1, Gwang-Sil Kim2, Dong-Ho Shin2, Jung-Sun Kim2,
Byeong-Keuk Kim2, Donghoon Choi2, Myeong-Ki Hong2, Yangsoo Jang2,
Young-Guk Ko2
1Division of Cardiology, Departement of Internal Medicine, Myongji Hospital,
Koyang, Korea, 2Division of Cardiology, Severance Cardiovascular Hospital, Yonsei
University College of Medicine, Seoul, Korea
Background: Cystatin C has emerged as a sensitive biomarker of renal function.
Early change in cystatin C based glomerular ﬁltration rate (CysC-GFR) has been
reported to predict contrast induced nephropathy (CIN). We evaluated whether
baseline and 24-h change in CysC-GFR after percutaneous cardiovascular intervention
using contrast medium (CM) can serve as a prognostic marker of CIN and cardio-
vascular mortality.
Methods: We evaluated 597 patients who underwent elective coronary (n¼357) and
peripheral (n¼240) intervention from 2010 September to 2013 August at Severance
Cardiovascular Hospital, Seoul, Korea. CIN was deﬁned as increase  25% and/or 
0.5 mg/dl in serum creatinine at 48-h after intervention compared from baseline.
Cystatin C and serum creatinine levels were measured before and at 24-h after the
procedure. Receiver operating characteristic (ROC) curve with area under the curve
(AUC) value were compared for prediction of CIN. Kaplan-Meier survival curve
analysis and Cox proportional hazards regression analysis were used to ﬁnd risk
factors of cardiovascular mortality.
Results: Increment of cystatin C level at 24-h from baseline was not able to predict
CIN. AUC value of 10, 20, and 30% increment of Cystatin C levels were 0.51, 0.53,
and 0.50, respectively. However, baseline CysC-GFR < 60 ml/min showed most
superior prediction of CIN (AUC 0.68, 95% Conﬁdence Interval 0.65 – 0.72, P<
0.0001) followed by contrast amount > 200cc (AUC 0.64, P¼0.0003), baseline
modiﬁcation of diet in renal disease (MDRD) GFR < 60 ml/min (AUC 0.63,
P¼0.0005). Although 24-h change in CIN CysC-GFR was not associated with car-
diovascular mortality, baseline CysC-GFR < 60 ml/min, baseline MDRD-GFR < 60
min/min, age  75 years were associated with increased cardiovascular mortality by
Kaplan-Meier survival curve analysis. In multivariate Cox regression analysis, only
baseline CysC-GFR < 60 was a signiﬁcant predictor of cardiovascular mortality
(hazard ratio 4.1, 95% CI 1.54 – 15.65, P¼0.0075).
Conclusions: Baseline CysC-GFR< 60 was a signiﬁcant predictor of CIN and cardiac
mortality after cardiovascular intervention and early change of cystatin C showed no
beneﬁt for CIN prediction or cardiac mortality.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/DrTCT-264
Impact of different deﬁnitions on prevalence of contrast induced nephropathy in
patients undergoing transcatheter aortic valve implantation
Stylianos A. Pyxaras1, Alexander Wolf1, Yuan Zhang1, Illkyu-Oliver Lee1,
Christoph Johann1, Thomas Schmitz1, Christoph Naber1
1Contilia Heart and Vascular Center, Essen, Germany
Background: Recently the Valve Academic Research Consortium (VARC) adopted
the Akute Kidney Injury (AKIN) system in the place of the Risk, Injury, and Failure,
Loss and End-stage kidney disease (RIFLE) system to deﬁne akute kidney injury
(AKI) following transcatheter aortic valve implantation (TAVI). In this study, we
sought to assess differences in prognostic accuracy between the two systems in our
real-world retrospective population of patients undergoing TAVI.
Methods: In the present study, 239 consecutive patients undergoing transfemoral
TAVI were prospectively enrolled. AKI was deﬁned: (1) according to the AKIN
system as a post-procedural creatinine increase of 0.3 mg/dl; or (2) according to the
RIFLE system as a post-procedural decrease of the creatinine clearance of at least 25%.
Results: Both AKIN and RIFLE system deﬁnitions were signiﬁcantly associated to
one-year mortality (binary logistic regression, respectively: (1) OR 3.2, 95%CI 1.5-
6.9, p¼0.003; and (2) OR 8.5, 95%CI 3.9-18.4, p< 0.001). However, the prognostic
accuracy of RIFLE was higher (AUC 0.704; p< 0.001) as with respect to AKIN (AUC
0.602; p¼0.037) for the primary end-point of one-year mortality.
Conclusions: In a non-selected patient population undergoing TAVI, the RIFLE system
had a higher prognostic accuracy in comparison to the currently proposedAKIN system.
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Contrast induced acute kidney injury in patients undergoing transcatheter aortic
valve implantation – interaction with left ventricular ejection fraction
Stylianos A. Pyxaras1, Alexander Wolf1, Thomas Schmitz1, Yuan Zhang1,
Illkyu-Oliver Lee1, Christoph Johann1, Christoph Naber1
1Contilia Heart and Vascular Center, Essen, Germany
Background: The prognostic relevance of direct contrast toxicity in patients under-
going transcatheter aortic valve implantation (TAVI) remains unclear, due to the
confounding hemodynamic effect of acute left ventricular ejection fraction (LVEF)
impairment on kidney function estimation.
Methods: In the present study, 239 consecutive patients undergoing transfemoral TAVI
were prospectively enrolled. Contrast induced acute kidney injury (CI-AKI) was deﬁned
according to the VARC-2 criteria as a post-procedural creatinine increase of0.3mg/dl.
Results: While LVEF and creatinine values at admission were not signiﬁcantly
associated to CI-AKI, their interaction term signiﬁcantly deﬁned CI-AKI (p¼0.033).
The long-term survival (1.71.4 years) was signiﬁcantly lower in the CI-AKI patient
group (log-rank¼5.1, p¼0.025). In the Cox-regression multivariate model analysis
CI-AKI was an independent predictor of mortality (HR 2.2, 95%CI 1.1-4.7, p¼0.034),
along with LVEF (HR 0.97, 95%CI 0.95-0.99, p¼0.012).
Conclusions: In a non-selected patient population undergoing TAVI, CI-AKI was
conﬁrmed as an independent predictor of clinical outcome. Interestingly, only the inter-
action between LVEF and baseline creatinine values was found to determine CI-AKI.Drug-Eluting Balloons and Local Drug Delivery
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PEPCAD-DES: A randomized, multicenter, single blinded trial comparing
paclitaxel coated balloon angioplasty with plain balloon angioplasty in drug-
eluting-stent restenosis – 3 year results
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Johannes Brachmann4, Jochen Wöhrle5
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Background: We evaluated the impact of paclitaxel-coated balloon angioplasty for treat-
ment of drug-eluting stent restenosis compared with uncoated balloon angioplasty alone.
Methods: In this prospective, single-blind, multicenter, trial we randomly assigned
110 patients with Instent-Restnosis of drug eluting stents to undergo treatment either
with paclitaxel coated balloon (SeQuent Please, BBraun, Melsungen) or balloon an-
gioplasty alone. Primary endpoint was in-stent late lumen loss at 6 months. Secondaryug-Eluting Balloons and Local Drug Delivery B77
